Siji Nian

446 total citations
29 papers, 287 citations indexed

About

Siji Nian is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Siji Nian has authored 29 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Siji Nian's work include IL-33, ST2, and ILC Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (5 papers). Siji Nian is often cited by papers focused on IL-33, ST2, and ILC Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (5 papers). Siji Nian collaborates with scholars based in China, Macao and Thailand. Siji Nian's co-authors include Qing Yuan, Yingchun Ye, Qing Yuan, Zhongkang Wang, Xue Wen, Youping Yin, Wenfeng Xu, Guangxi Wang, Luhua Zhang and Yung‐Fu Chang and has published in prestigious journals such as Applied and Environmental Microbiology, Frontiers in Immunology and Enzyme and Microbial Technology.

In The Last Decade

Siji Nian

28 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siji Nian China 11 104 85 43 43 42 29 287
Naveen Kumar Nair India 8 211 2.0× 38 0.4× 56 1.3× 23 0.5× 24 0.6× 8 379
D. C. Webb Australia 9 128 1.2× 80 0.9× 51 1.2× 11 0.3× 15 0.4× 10 350
Dhanya Ramachandran Germany 8 86 0.8× 81 1.0× 27 0.6× 11 0.3× 37 0.9× 22 272
Barrett L. Updegraff United States 6 169 1.6× 149 1.8× 30 0.7× 5 0.1× 30 0.7× 10 375
Martijn Cordes Netherlands 8 169 1.6× 64 0.8× 60 1.4× 23 0.5× 5 0.1× 13 295
Edvīns Miklaševičs Latvia 13 205 2.0× 18 0.2× 88 2.0× 19 0.4× 35 0.8× 66 454
Kami Chiotti United States 10 361 3.5× 48 0.6× 75 1.7× 9 0.2× 14 0.3× 13 490
Liuhai Zheng China 11 103 1.0× 82 1.0× 44 1.0× 23 0.5× 2 0.0× 19 322
Jiangfeng Qiu China 11 178 1.7× 20 0.2× 32 0.7× 6 0.1× 57 1.4× 23 381
Anne Mey France 11 239 2.3× 175 2.1× 35 0.8× 10 0.2× 5 0.1× 20 479

Countries citing papers authored by Siji Nian

Since Specialization
Citations

This map shows the geographic impact of Siji Nian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siji Nian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siji Nian more than expected).

Fields of papers citing papers by Siji Nian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siji Nian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siji Nian. The network helps show where Siji Nian may publish in the future.

Co-authorship network of co-authors of Siji Nian

This figure shows the co-authorship network connecting the top 25 collaborators of Siji Nian. A scholar is included among the top collaborators of Siji Nian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siji Nian. Siji Nian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Bo, Qin Liu, Lin Li, et al.. (2025). Therapeutic effect of fully human anti-Nrp-1 antibody on non–small cell lung cancer in vivo and in vitro. Cancer Immunology Immunotherapy. 74(2). 50–50.
2.
Chen, Han, Xiaoke Sun, Lin Li, et al.. (2025). Zebrafish xenografts in breast cancer research. Frontiers in Immunology. 16. 1540610–1540610. 1 indexed citations
3.
Li, Lin, Siji Nian, Qin Liu, et al.. (2024). Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration. International Immunopharmacology. 132. 111926–111926. 1 indexed citations
4.
Cao, Shuang, Han Chen, Siji Nian, et al.. (2024). The role of DC subgroups in the pathogenesis of asthma. Frontiers in Immunology. 15. 1481989–1481989. 1 indexed citations
5.
Huang, Xueyuan, Hao Chi, Lin Li, et al.. (2023). An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma. Genes. 14(1). 124–124. 40 indexed citations
6.
Ye, Yingchun, Guoping Huang, Yi Li, et al.. (2022). EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthma. International Immunopharmacology. 111. 109106–109106. 2 indexed citations
7.
Zhang, Lulu, Bo Zhang, Lin Li, et al.. (2022). Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer. Journal of Cancer Research and Clinical Oncology. 149(5). 2243–2258. 4 indexed citations
8.
Wen, Xue, Siji Nian, Yaqi Yang, et al.. (2022). Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma. International Immunopharmacology. 106. 108606–108606. 9 indexed citations
9.
Zhang, Xingli, Xue Wen, Guoping Huang, et al.. (2022). The onset, development and pathogenesis of severe neutrophilic asthma. Immunology and Cell Biology. 100(3). 144–159. 28 indexed citations
10.
Zhang, Haiyan, Zhi Hu, Hong Yu, et al.. (2021). Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining. Frontiers in Oncology. 11. 608113–608113. 10 indexed citations
11.
Wen, Xue, Xingli Zhang, Siji Nian, et al.. (2021). Title of article: Mucosal-associated invariant T cells in lung diseases. International Immunopharmacology. 94. 107485–107485. 12 indexed citations
12.
Chen, Qi, Siji Nian, Yingchun Ye, et al.. (2021). The Emerging Roles of T Helper Cell Subsets and Cytokines in Severe Neutrophilic Asthma. Inflammation. 45(3). 1007–1022. 11 indexed citations
13.
Yang, Yaqi, Siji Nian, Lin Li, et al.. (2021). Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy. Bioengineered. 12(2). 10379–10400. 9 indexed citations
14.
Huang, Guoping, et al.. (2021). [House dust mite extract activates EphA2-STAT3/p38 MAPK signaling pathway in airway epithelial cells to mediate airway inflammation].. PubMed. 37(1). 31–38. 2 indexed citations
15.
Li, Ying, Guangxi Wang, Chengwen Li, et al.. (2019). blaNDM-5 carried by a hypervirulent Klebsiella pneumoniae with sequence type 29. Antimicrobial Resistance and Infection Control. 8(1). 140–140. 46 indexed citations
16.
Nian, Siji, et al.. (2016). Development and identification of fully human scFv-Fcs against Staphylococcus aureus. BMC Immunology. 17(1). 8–8. 17 indexed citations
17.
Ye, Yingchun, Siji Nian, Wenfeng Xu, et al.. (2015). Construction and expression of human scFv-Fc against interleukin-33. Protein Expression and Purification. 114. 58–63. 2 indexed citations
18.
Yuan, Qing, Li Huang, Xu Wang, et al.. (2012). Construction of Human Nonimmune Library and Selection of scFvs Against IL-33. Applied Biochemistry and Biotechnology. 167(3). 498–509. 9 indexed citations
19.
Yuan, Qing, et al.. (2009). Development of a PCR-based diagnostic tool specific to wheat dwarf bunt, caused by Tilletia controversa. European Journal of Plant Pathology. 124(4). 585–594. 18 indexed citations
20.
Yuan, Qing, Zhongkang Wang, Siji Nian, et al.. (2008). Screening of High-Affinity scFvs From a Ribosome Displayed Library Using BIAcore Biosensor. Applied Biochemistry and Biotechnology. 152(2). 224–234. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026